Skip to main content

Lapse in Appropriations

Please note that a lapse in appropriations has caused GAO to shut down its operations. Therefore, GAO will not be able to publish reports or otherwise update this website until GAO resumes operations. In addition, the vast majority of GAO personnel are not permitted to work. Consequently, calls or emails to agency personnel may not be returned until GAO resumes operations. For details on how the bid protest process will be handled during the shutdown, please see the legal decisions page. For information related to the GAO Personnel Appeals Board (PAB), please see the PAB webpage.

Blood Safety: Recalls and Withdrawals of Plasma Products

T-HEHS-98-166 Published: May 07, 1998. Publicly Released: May 07, 1998.
Jump To:

Highlights

GAO discussed the amount of plasma products, and in particular the amount of intravenous immune globulin (IVIG), that was being lost due to removal of products from the market, focusing on the: (1) number of recent product recalls and withdrawals; (2) reasons for these actions; (3) different types of plasma products affected; (4) amount of product that has been returned as a result of these actions; and (5) current shortage of IVIG of reducing the number of donors for each plasma product.

Full Report

Full Report (14 pages)

Media Inquiries

Sarah Kaczmarek
Managing Director
Office of Public Affairs
media@gao.gov

Public Inquiries

Contact Us

Topics

Health Care
Health care servicesHealth hazardsMedical suppliesNeurological diseasesProduct recallsProduct safetyVaricellaFinancial derivativesPublic healthSurgery